Skip to main content
Clinical Trials/CTRI/2024/07/070971
CTRI/2024/07/070971Not yet recruitingPhase 3 4

A Comparative Clinical Study Of Ayorajadi Churna And Nisha Loha In Pandu (Iron Deficiency Anaemia)

Post Graduate Institute Of Ayurved Jodhpur1 site in 1 country60 target enrollmentStarted: August 10, 2024Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To assess the differences in changes in iron deficiency anemia between Ayorajadi churna and Nisha loha.

Study Overview

Brief Summary

Number of Patients: 60 (each group have 30 patients)

Type of Study: open-label

Drugs: -Group A:  Ayorajadi Churna

Group B, Nisha loha

Dose: Group A: Ayorajadi Churna, 1 gram orally twice a day after meal

Anupan-  Madhu, and Sarpi

Route: Oral Route

Group B:  Nisha loha 250 mg orally twice a day after meal

Anupan-   Madhu, and Sarpi

Route:      Oral Route

Duration of Study:  45 days

Follow-up: Each 15th Days during study and after 15th  Days of completion of study

Purpose of the Trial:To evaluate the effect of Ayorajadi Churna on Pandu in comparison with Nisha loha.

Study Design

Study Type
Interventional
Allocation
Other
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Pandu Roga diagnosed according to subjective and objective parameters Age group between above 18 years and below 60 years of either sex having cardinal symptoms of Pandu.
  • •Blood sample showing Hb percentage in range [in men 7–13 g/dl and in females 7–12 g/dl] Patients willing to participate in clinical trials.

Exclusion Criteria

  • •Patients suffering from systemic diseases like renal disorders, heart disease, cancer, or tuberculosis.
  • •Patients with an age below 18 years and above 60 years.
  • •Patients with Hb% less than 7 g/dl.
  • •Pregnant &lactating women’s.

Outcomes

Primary Outcomes

To assess the differences in changes in iron deficiency anemia between Ayorajadi churna and Nisha loha.

Time Frame: 45 days

Secondary Outcomes

  • changes in the clinical sign & symptoms of Pandu.(45days)

Investigators

Sponsor
Post Graduate Institute Of Ayurved Jodhpur
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Rahul Suthar

PG Department Of Kriya Sharir , Dr. S.R. Rajasthan Ayurved University, Jodpur, Rajasthan, India

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2/3
Management of Kushtha Roga(Psoriasis)through AyurvedaDiseases of the skin and subcutaneous tissue. Ayurveda Condition: KUSHTHAM, (2) ICD-10 Condition: L00-L99||Diseases of the skin and subcutaneous tissue. Ayurveda Condition: KUSHTHAM, (3) ICD-10 Condition: L409||Psoriasis, unspecified. Ayurveda Condition: KUSHTHAM, (4) ICD-10 Condition: L409||Psoriasis, unspecified. Ayurveda Condition: KUSHTHAM,
CTRI/2024/11/076773Post Graduate Institute of Ayurved Jodhpur Rajasthan 34203740
Not yet recruiting
Phase 1
A Study on the effect of Yava-Amlaka Churna with Warm Water and Triphala with Honey in ObesityKshudha Adhikya – Excessive hunger Trishna Adhikya – Excessive thirst Nidra Adhikya – Excessive sleep shudra Svasa – Shortness of breath on exertion Klanta – Fatigue or tiredness
CTRI/2025/07/091615Uttaranchal Ayuvedic College60
Not yet recruiting
Phase 2
A Clinical Study to assess the effect of Rajanyadi Churna in the management of Iron Deficiency Anemia (Pandu Rago) in Children.Iron deficiency. Ayurveda Condition: PANDUROGAH,
CTRI/2025/10/096288Gunjal Priya30
Not yet recruiting
Phase 2/3
A Comparative Study Of Efficacy Of Chaturbeej Churna With Latakaranj Churna In The Management Of Garbhashay ShodhanOther specified diseases and conditions complicating pregnancy, childbirth and the puerperium. Ayurveda Condition: SUTIKA,
CTRI/2024/10/076031Tilak Ayurved Mahavidyalay50
Not yet recruiting
Not Applicable
Role of Nidrakar Churna and Shiropichu with Ksheerbala Taila in improving sleep among patients with InsomniaInsomnia not due to a substance orknown physiological condition. Ayurveda Condition: NIDRANASAH/ASVAPNAH,
CTRI/2025/09/095493Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan60